Outcomes

If the virus has remained undetectable after six months from the end of therapy, you are considered a sustained viral responder. If the virus is undetectable while you are on therapy, but then later returns when you stop, you are considered a relapser. If the virus never becomes undetectable in your blood during therapy, you are considered a nonresponder.

The staff of the Liver Program at UNC is committed to continuing to look for new treatment opportunities for people who still need treatment options. Please go to our research section for current information about ongoing studies.